Personalized Computerized Inhibitory Control Training for OCD
- Conditions
- Obsessive-Compulsive Disorder
- Registration Number
- NCT02378896
- Lead Sponsor
- New York State Psychiatric Institute
- Brief Summary
This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.
- Detailed Description
This study will evaluate the effectiveness of a computerized training program (called Personalized Computerized Inhibitory Training, or PCIT) coupled with cognitive behavioral therapies (CBT) consisting of Exposures and Response Prevention in treating obsessive compulsive disorder (OCD) in patients who previously underwent CBT, but still have residual symptoms.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 11
- Principal diagnosis of OCD (assessed by SCID).
- Clinically significant OCD symptoms (Y-BOCS score of at least 16).
- Have a history of completing a trial of at least 1 EX/RP sessions.
- Have access to a computer or laptop.
- Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID).
- Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system.
- Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry.
- Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded).
- Active suicidality warranting immediate clinical care.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Obsessive-compulsive symptoms measured after 3 weeks of treatment 3 weeks measured by Yale Brown Obsessive Compulsive Scale (YBOCS)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
New York State Psychiactic Institute
🇺🇸New York, New York, United States
New York State Psychiactic Institute🇺🇸New York, New York, United States